Daly Mark J, Pearce Alexandra V, Farwell Lisa, Fisher Sheila A, Latiano Anna, Prescott Natalie J, Forbes Alastair, Mansfield John, Sanderson Jeremy, Langelier Diane, Cohen Albert, Bitton Alain, Wild Gary, Lewis Cathryn M, Annese Vito, Mathew Christopher G, Rioux John D
The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
Eur J Hum Genet. 2005 Jul;13(7):835-9. doi: 10.1038/sj.ejhg.5201403.
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the gastrointestinal system known as the inflammatory bowel diseases (IBD). Recently, Stoll and colleagues reported a novel finding of genetic variation in the DLG5 gene that is associated with IBD (CD and UC combined). We present here a study of the genetic variation described in that report in two well-powered, independent case-control cohorts and one family-based collection, and confirm the proposed association between IBD and the R30Q variant of DLG5 in two of the three studies. We are, however, unable to replicate the other proposed association to the common haplotype described in Stoll et al and suggest that this other finding could conceivably have been partially a statistical fluctuation and partially a result of LD with the replicated R30Q association. This study provides support for the hypothesis that DLG5 constitutes a true IBD risk factor of modest effect.
克罗恩病(CD)和溃疡性结肠炎(UC)是胃肠道的慢性炎症性疾病,统称为炎症性肠病(IBD)。最近,斯托尔及其同事报告了一项关于DLG5基因遗传变异的新发现,该变异与IBD(CD和UC合并)相关。我们在此展示了一项针对该报告中所描述的遗传变异的研究,该研究涉及两个样本量充足的独立病例对照队列以及一个基于家系的样本集,并在三项研究中的两项中证实了IBD与DLG5的R30Q变异之间的拟关联。然而,我们无法重复斯托尔等人所描述的与常见单倍型的另一种拟关联,并表明这一其他发现可能部分是统计波动,部分是与已复制的R30Q关联的连锁不平衡的结果。本研究为DLG5构成一个效应适度的真正IBD风险因素这一假说提供了支持。